Home Categories Pharmaceutical intermediates CHIR-99021 (CT99021) HCl
A2475312

CHIR-99021 (CT99021) HCl , ≥98% , 252917-06-9

Synonym(s):
6-(2-(4-(2,4-Dichlorophenyl)-5-(4-methyl-1H-imidazol-2-yl)-pyrimidin-2-ylamino)ethyl-amino)-nicotinonitrile;6-[[2-[[4-(2,4-Dichlorophenyl)-5-(5-methyl-1H-imidazol-2-yl)-2-pyrimidinyl]amino]ethyl]amino]-3-pyridinecarbonitrile

CAS NO.:252917-06-9

Empirical Formula: C22H18Cl2N8

Molecular Weight: 465.34

MDL number: MFCD11846251

EINECS: 809-015-4

Pack Size Price Stock Quantity
5MG RMB389.60 In Stock
25MG RMB752.80 In Stock
100MG RMB2173.60 In Stock
others     Enquire
Update time: 2022-07-08

PRODUCT Properties

Boiling point: 784.1±70.0 °C(Predicted)
Density  1.48
storage temp.  -20°C
solubility  DMSO: soluble2mg/mL, clear (warmed)
pka 11.92±0.10(Predicted)
form  powder
color  white to light brown
Stability: Stable for 2 years from date of purchase as supplied. Solutions in DMSO may be stored at -20° for up to 3 months.
InChIKey AQGNHMOJWBZFQQ-UHFFFAOYSA-N
CAS DataBase Reference 252917-06-9

Description and Uses

CHIR99021 is an aminopyrimidine derivative that is an extremely potent glycogen synthase kinase (GSK) 3 inhibitor, inhibiting both GSK3β (IC?? = 6.7 nM) and GSK3α (IC?? = 10 nM). GSK3 is a serine/threonine kinase that is a key inhibitor of the WNT pathway; therefore CHIR99021 functions as a WNT activator. It shows little activity against a large panel of kinases including CDK2 and other serine/threonine kinases such as MAPK and PKB (Bain et al.).
CHIR99021 promotes self-renewal potential of embryonic stem cells (ESCs) of mice by inhibiting glycogen synthase kinase-3 (GSK-3) activity and potentiates the upregulation of β-catenin and c-Myc functions. CHIR99021 promotes self-renewal of ESCs by modulating transforming growth factor β (TGF-β), Notch and mitogen-activated protein kinases (MAPK) signaling pathways. CHIR99021 is an agonist of wingless/integrated (wnt) signalling, upregulates cyclinA expression and promotes cell proliferation in non-small-cell lung cancer (NSCLC) cell lines.

A specific GSK-3 inhibitor of GSK-3β and GSK-3α with IC50s of 5 nM and 10 nM, respectively.

Safety

Symbol(GHS) 
GHS06
Signal word  Danger
Hazard statements  H300-H315-H319-H335
Precautionary statements  P261-P264-P301+P310-P305+P351+P338
Hazard Codes  T
Risk Statements  25-36/37/38
Safety Statements  26-36/37/39-45
RIDADR  UN 2811 6.1 / PGIII
WGK Germany  3
HS Code  29335990

RELATED PRODUCTS